Monaco Asset Management SAM - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Monaco Asset Management SAM ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$490,772
+27.5%
377,517
+58.9%
0.15%
+36.4%
Q2 2023$384,778
+0.7%
237,517
+32.4%
0.11%
-8.5%
Q1 2023$381,981
-37.4%
179,334
+8.7%
0.12%
-36.4%
Q4 2022$610,500
-11.9%
165,000
-82.3%
0.18%
-30.8%
Q3 2022$693,000
-4.3%
931,4000.0%0.27%
-15.6%
Q2 2022$724,000
+782.9%
931,400
+924.6%
0.32%
+854.5%
Q1 2022$82,00090,9000.03%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders